Managing At The Market Programs
When To Use
- Establishing a new ATM equity offering program under an effective shelf registration (Form S-3 or F-3)
- Selecting or replacing sales agents for an existing ATM facility
- Setting or adjusting volume limitations, pricing parameters, and blackout windows
- Coordinating ongoing disclosure obligations during active ATM sales periods
- Evaluating ATM program utilization against remaining shelf capacity and market conditions
- Preparing for program renewal or amendment following shelf registration expiration
Inputs To Gather
- Shelf registration details: Effective S-3/F-3 filing date, total registered capacity, amounts already sold, remaining availability
- Issuer profile: Current market cap, average daily trading volume (ADTV), float, share price history, and outstanding share count
- Sales agent candidates: Broker-dealer proposals with commission rates (typically 1–3%), distribution capabilities, sector coverage, and research presence
- Volume constraints: Board-authorized maximum issuance, any contractual caps (e.g., credit facility covenants, shareholder dilution thresholds)
- Regulatory posture: WKSI status, baby shelf limitation applicability (public float < $75M triggers one-third cap), [VERIFY] current Form S-3 eligibility requirements
- Internal blackout calendar: Earnings windows, material non-public information (MNPI) periods, insider trading policy restrictions
- Existing agreements: Prior ATM equity distribution agreements, lock-up commitments, registration rights obligations
Workflow
Assess shelf capacity and eligibility
- Confirm S-3/F-3 effectiveness and remaining registered amount
- Calculate baby shelf limitation if applicable: one-third of public float measured within 60 days of each sale [VERIFY]
- Determine whether a new prospectus supplement is required or an existing one can be amended
Select sales agent(s)
- Evaluate agent proposals on commission structure, execution quality, sector expertise, and compliance infrastructure
- For multi-agent programs, define allocation methodology (exclusive vs. non-exclusive, rotating vs. concurrent)
- Negotiate equity distribution agreement terms: commission rate, settlement cycle (T+1/T+2), indemnification, termination provisions, and expense allocation
Establish volume and pricing parameters
- Set daily volume limits as a percentage of ADTV (common threshold: 10–25% of ADTV to minimize market impact)
- Define minimum price floors, VWAP benchmarks, or limit-order instructions
- Document board-authorized maximum aggregate dollar amount and share count
- Build in automatic suspension triggers tied to price thresholds or volume spikes
Configure disclosure and compliance framework
- File prospectus supplement with ATM program terms (Rule 424(b) filing)
- Establish bring-down procedures: comfort letters, legal opinions, and officer certificates at program inception and periodic intervals (typically quarterly)
- Set up Form 8-K reporting for material sales milestones [VERIFY] and 10-Q/10-K footnote disclosure of shares sold, proceeds, and commissions
- Coordinate Regulation M compliance—confirm issuer and agent are not engaged in prohibited stabilization or market-making during distribution
Manage ongoing execution
- Maintain a rolling sales log tracking date, shares sold, average price, gross/net proceeds, and cumulative utilization
- Monitor blackout windows and halt sales instructions during MNPI periods
- Track sell-down against baby shelf cap, recalculating float-based limits each measurement period
- Conduct periodic agent performance reviews comparing execution quality to VWAP benchmarks
Report and optimize
- Produce periodic management summaries showing program utilization, weighted-average sale price, dilution impact, and remaining capacity
- Compare realized cost of capital (commission + market impact) against alternative financing options
- Recommend timing adjustments based on stock price performance, volatility, and upcoming catalysts
Output
A management report covering:
- Program status dashboard: Shelf capacity remaining, cumulative shares sold, gross and net proceeds, weighted-average price, and commission expense
- Agent performance summary: Execution quality by agent (price achieved vs. VWAP, fill rates, settlement issues)
- Compliance tracker: Bring-down schedule, upcoming filing deadlines, blackout window calendar, and baby shelf recalculation dates
- Utilization analysis: Pace of sales relative to ADTV, market impact assessment, and dilution waterfall
- Recommendations: Suggested parameter adjustments, agent reallocation, or program suspension/acceleration based on market conditions
Quality Checks
- Confirm shelf registration remains effective and no post-effective amendment is pending that would suspend sales
- Validate baby shelf calculations use the correct measurement date and public float figure [VERIFY]
- Ensure all bring-down deliverables (comfort letters, opinions, certificates) are current and not stale-dated
- Cross-check cumulative sales figures against transfer agent records and agent trade confirmations
- Verify blackout enforcement—no sales occurred during closed trading windows or MNPI periods
- Confirm all Rule 424(b) filings and Form 8-K/10-Q disclosures are timely and consistent with the sales log
- Flag any approaching volume thresholds (e.g., within 10% of authorized maximum or baby shelf cap) for escalation